Pegylated and nanoparticle-conjugated sulfonium salt photo triggers necrotic cell death
Authors Fadhel AA, Yue X, Ghazvini Zadeh EH, Bondar MV, Belfield KD
Received 10 June 2016
Accepted for publication 22 August 2016
Published 18 November 2016 Volume 2016:11 Pages 6161—6168
Checked for plagiarism Yes
Review by Single anonymous peer review
Peer reviewer comments 3
Editor who approved publication: Professor Carlos Rinaldi
Alaa A Fadhel,1 Xiling Yue,1 Ebrahim H Ghazvini Zadeh,1 Mykhailo V Bondar,2 Kevin D Belfield3
1Department of Chemistry, University of Central Florida, Orlando, FL, USA; 2Institute of Physics NASU, Kiev, Ukraine; 3Department of Chemistry and Environmental Science, College of Science and Liberal Arts, New Jersey Institute of Technology, University Heights, Newark, NJ, USA
Abstract: Photodynamic therapy (PDT) processes involving the production of singlet oxygen face the issue of oxygen concentration dependency. Despite high oxygen delivery, a variety of properties related to metabolism and vascular morphology in cancer cells result in hypoxic environments, resulting in limited effectiveness of such therapies. An alternative oxygen-independent agent whose cell cytotoxicity can be remotely controlled by light may allow access to treatment of hypoxic tumors. Toward that end, we developed and tested both polyethylene glycol (PEG)-functionalized and hydrophilic silica nanoparticle (SiNP)-enriched photoacid generator (PAG) as a nontraditional PDT agent to effectively induce necrotic cell death in HCT-116 cells. Already known for applications in lithography and cationic polymerization, our developed oxygen-independent PDT, whether free or highly monodispersed on SiNPs, generates acid when a one-photon (1P) or two-photon (2P) excitation source is used, thus potentially permitting deep tissue treatment. Our study shows that when conjugated to SiNPs with protruding amine functionalities (SiNP–PAG9), such atypical PDT agents can be effectively delivered into HCT-116 cells and compartmentalize exclusively in lysosomes and endosomes. Loss of cell adhesion and cell swelling are detected when an excitation source is applied, suggesting that SiNP–PAG9, when excited via near-infrared 2P absorption (a subject of future investigation), can be used as a delivery system to selectively induce cell death in oxygen-deprived optically thick tissue.
Keywords: oxygen-independent photodynamic therapy, photoacid generator, silica nanoparticles, stimuli-responsive, sulfonium salt
The clinical usefulness of light was first recognized some 3,000 years ago when it was used to treat rickets, psoriasis, and other common ailments.1 More recently, the term photodynamic therapy (PDT) surfaced and has been used to describe the use of light to treat a variety of diseases, including cancer.2–5 Specifically, over the last 100 years, great strides have been made in developing photodynamic therapies for use in the clinical setting. PDT hinges on a few key components. The first component is the photosensitizer, the photosensitive material that targets diseased tissue, akin to chemotherapeutic agents. Biocompatibility and potential for targeting are important to the optimization of this component. The second component is the irradiation of the target area with light of a specific wavelength. Excitation of the photosensitive material to a triplet state in the presence of oxygen results in triplet–triplet annihilation, producing cytotoxic reactive oxygen species (ROS) that destroy cellular components, thus triggering cell death. Therefore, the success of photodynamic therapeutics depends largely on the photosensitizer concentration throughout the tissue, adequate intracellular oxygen concentration, and proper source of excitation. The discovery of this process was extremely promising in providing a more targeted, regulated method of cancer treatment. However, one of the main drawbacks of this method of PDT is that it is oxygen dependent. Although cancer cells have abnormally high vascularization, intracellular oxygen concentration is low due to poor morphology of the vessels and abnormally high metabolic and oxygen consumption rates, which are characteristics of cancerous tissues.2 Without oxygen available to interact with the photosensitizer, ROS cannot be formed and the therapeutic method becomes relatively ineffective or far less effective than intended.
In addressing the aforementioned issue, we recently took an alternative approach in attempting to trigger cell death by employing a photoresponsive agent with low dark cytotoxicity. Rather than producing ROS as the main “damaging” component, we used a non-toxic sulfonium-based photoacid generator (PAG) to cause intracellular pH imbalance.6 Upon proper light excitation, the PAG lowers the pH in the moderately pH-sensitive intracellular environment; the acidic environment thus created leads to the malfunction and destruction of many cellular components, likely including key enzymes. This process is considered an oxygen-independent PDT (OI-PDT) and, essentially, relies on two main components, the sulfonium salt distribution in the affected area and a proper source of excitation, rather than the three components mentioned earlier. In essence, reducing the number of variables in the therapeutic process development improves the chances of success in material design and subsequent treatment.
Given the hydrophobic nature of PAGs prepared in our preliminary study,6 we opted to introduce a polyethylene glycol (PEG) unit that can confer hydrophilicity to the PDT agent while maintaining its photo-induced cytotoxicity. Along the same line, we prepared highly monodispersed silica nanoparticles (SiNPs) functionalized with amines that served as handles to covalently bond PAG molecules via an amide linkage. The incorporation of the PAG into a nanomaterial delivery formulation is also intended to improve delivery properties of the proposed PDT agent as nanomaterials have emerged as a promising solution to the issues of cellular specificity, time-controlled delivery, and aqueous solubility.7,8 Herein, we report the design, synthesis (Scheme 1 and Supplementary material), and investigation of a new PAG and its incorporation on SiNPs (SiNP–PAG9), which offers better solubility in aqueous media, greater efficacy than water-soluble PEGylated PAG (PEG–PAG9), and low dark cytotoxicity.
PEG–PAG9 and SiNP–PAG9 were designed having similar A–π–A′ core structure to the one reported in our initial work, where the two acceptor units (A), −NO2 and −SPh2+, flank a fluorenyl-stilbene π-spacer. Using the C(9) of fluorene 1 to attach a handle for further functionalization, a propanoic acid unit was added as depicted in Scheme 1. Initially, treatment of 1 with one equivalent of n-BuLi at −78°C generated a carbanion, stabilized by resonance through the fluorene π-system; this was followed by careful addition of ethyl bromide to afford the monoalkylated intermediate 2. Bi-substituted fluorene 3 was obtained through a Triton B-assisted Michael addition of 2 with acrylonitrile in satisfactory yield (77%).
Materials and methods
Although later stages of the synthesis that use aqueous acids have resulted in the hydrolysis of the nitrile moiety, such acidic hydrolysis was incomplete and often resulted in low yields and multiple side products. Therefore, we opted to hydrolyze the nitrile group using aqueous NaOH to afford the carboxylic acid derivative 4 in good yield. Subsequent intermediates 5–9 were prepared following our reported procedure to afford PAG 9 in ~61% yield over four steps. This compound was conjugated to an amine-terminated PEG moiety by preparing the benzotriazole intermediate in situ, followed by the addition of the amine-terminated PEG to afford PEG–PAG9 in 77% yield. On the other hand, SiNPs having amine appendages SiNP(NH2)n (preparation detailed in the Supplementary material) were treated with 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide condensation agent, followed by the addition of an excess of PAG 9; the good solubility of PAG 9 in water allowed the dialysis of the resulting SiNP–PAG9 to separate any unreacted PAGs. Surface modification of SiNP(NH2)n by addition of PAG 9 molecules was first assessed using a Zetasizer Nano system (Malvern Instruments, Malvern, UK), where such addition resulted in particle size increase from an average of 4 nm to 9 nm (Supplementary material). In addition, the nuclear magnetic resonance (NMR) spectrum of SiNP–PAG9 in D2O (Supplementary material) showed the presence of peaks in the aromatic region that corresponded to PAG 9, hence verifying the successful functionalizing of the SiNPs with the PDT (PAG) molecules.
Next, the photophysical properties of PEG–PAG9 and SiNP–PAG9 were examined to ensure that the magnitude of photoacid generation is preserved after modification. Initially, the absorption profiles of PEG–PAG9 and SiNP–PAG9 were obtained in water, where both show a similar absorption band to previously reported PL-127®-encapsulated PAG, with an absorption λmax of 384 nm. More importantly, the photoacid generation quantum yield () of PEG–PAG9 was maintained at ~0.4 (Supplementary material), suggesting that the aqueous environment has little effect on the relevant photophysical properties of PEG–PAG9. Furthermore, the pH drop inside cell lysosomes was estimated by recording the changes in the absorption intensity of Rhodamine B (RhB) base. Conceptually, it is safe to assume that the number of protons generated by PEG–PAG9 upon exposure is the same as the number of RhB base molecules converted to RhB+, which is visualized as an increase in the absorption peak at ca. 555 nm (Figure 1A). Extrapolation of the calibration curve (Figure 1B) suggests that 50 μM of PEG–PAG9 would result in an increase of [H+]lysosomal by 9.1×10−6 M after a radiation dose of 10 min; consequently, the lysosomal pH would be reduced by at least 0.3 pH units to ~≤4.4 (Supplementary material).9
In order to evaluate the intrinsic toxicity of PEG–PAG9 and SiNP–PAG9, cell viability assays with CellTiter 96® AQueos One Solution Reagent (Promega Corporation, Fitchburg, WI, USA) were performed in the dark (dark viability) to prevent the production of acid and determine suitable concentration for effective PDT (Supplementary material). In this regard, HCT-116 cells (human colorectal carcinoma) were incubated with various concentrations of PEG–PAG9 and SiNP–PAG9 for 24 h at 37°C. The results showed that PEG–PAG9 has very low dark cytotoxicity, even at 100 μM dose concentration (Figure 2A). On the other hand, cell viability decreased from 99% to 75% when SiNP–PAG9 loading was doubled from 10 μM to 20 μM (Figure 2B). In order to further assess the cytotoxicity of PDT agents, post-exposure viability assays were performed using 50 μM and 10 μM of PEG–PAG9 and SiNP–PAG9, respectively. As can be seen in Figure 3, exposure of HCT-116 cultures incubated with PEG–PAG9 prompted a drop from 97% viability to 64% viability within 10 min. Within the same exposure timeframe, cultures incubated with SiNP–PAG9 experienced a reduction in viability from 98% to 42%. Such a drastic decrease in cell viability can be the result of PAG distribution within the lysosomes and endosomes. Mechanistically, photoexcitation of PAG 9 molecules that are densely grafted on SiNP(NH2)n generates a highly localized dose of protonated species, and, thus, a greater localized pH drop. Consequently, a localized surge in the protonated species concentration creates an acidic microenvironment that could override mechanisms by which cells tend to regulate intracellular [H]+, resulting in severe cytoplasmic acidification and inducing cell death.10 Although this report is largely qualitative, the error bars of the cell viability in Figures 2 and 3 provide some insight into the statistical significance of the results. Thus, SiNP–PAG9 exhibits high cytotoxicity at very low concentration and short exposure time.
Figure 2 Dark cytotoxicity of HCT-116 cells incubated with (A) PEG–PAG9 and (B) SiNP–PAG9.
Figure 3 Post-exposure (377 nm, 5.4 mW/cm2) viability of HCT-116 cells with (A) PEG–PAG9 (50 μM) and (B) SiNP–PAG9.
In order to determine the localization of PEG–PAG9 in HCT 116 cells, LysoTracker Green (Thermo Fisher Scientific, Waltham, MA, USA), a commercial dye that localizes in lysosomes after cell uptake, was used along with PEG–PAG9. Fluorescence of PEG–PAG9 was collected inside cells (Figure 4A–C), showing a good uptake efficiency of PEG–PAG9. Overlay image (Figure 4D) exhibited good colocalization between PEG–PAG9 and LysoTracker Green, which indicated that PEG–PAG9 mainly built up in lysosomes and endosomes. Next, we verified the reduced lysosomal pH by employing LysoSensor Green as a suitable intracellular pH sensor.6 Since the fluorescence quantum yield of LysoSensor Green increases in increasingly acidic environments,11 fluorescence intensity as a function of exposure time was studied, which showed a drop in intralysosomal pH following irradiation in HCT-116 cells incubated with PEG–PAG9 (Figure 5 and Supplementary material).
As demonstrated in our previous study,6 time-lapsed micrographs (Figure 6) of HCT-116 cells incubated with PEG–PAG9 and SiNP–PAG9 (Figures 6 and 7, respectively) show significant cell swelling, loss of cell adhesion that is followed by a “blebbing”-like activity, which is a characteristic of necrotic cell death. Figure 8 shows a simplified Jablonski diagram summarizing the process of photoacid generation by either one-photon or two-photon (2P) excitation.
Figure 7 Time-lapse images of HCT-116 cells incubated with SiNP–PAG9 show loss of cell adhesion (yellow arrows), blebbing-like activity (blue arrows), and cell swelling (red arrows).
We demonstrated that sulfonium salts can be used to selectively induce cell death by photoexcitation. PAGs induced necrotic cell death by creating a pH imbalance in the HCT-116 cells via generation of photoacid within the lysosomes. OI-PDT was shown to be effective using water-soluble PAG molecules. Higher efficacy was achieved when these PAG molecules were conjugated to silica-based nanoparticles, resulting in a higher cytotoxic effect. Ultimately, near-infrared (IR) 2P excitation of the water-soluble PAG should afford deep tissue excitation and PDT. Thus, light-guided acid generation could be considered an attractive tool for treatment of hypoxic tumors and other diseases. Currently, our efforts are focused on evaluating the prepared PAGs in vivo and for 2P excitation in the near-IR spectral range.
We wish to acknowledge support from the National Science Foundation (CBET-1517273).
The authors report no conflicts of interest in this work.
Spikes JD. In: Berghausen RV, Jori G, Land EJ, Truscott TH, editors. Primary Photoprocesses in Biology and Medicine. New York, NY: Plenum Press; 1985:209–227.
Mroz P, Yaroslavsky A, Kharkwal GB, Hamblin MR. Cell death pathways in photodynamic therapy of cancer. Cancers. 2011;3(2):2516.
Zhu TC, Finlay JC, Hahn SM. Determination of the distribution of light, optical properties, drug concentration, and tissue oxygenation in-vivo in human prostate during motexafin lutetium-mediated photodynamic therapy. J Photochem Photobiol B. 2005;79(3):231.
Moore RB, Chapman JD, Mercer JR, et al. Measurement of PDT-induced hypoxia in Dunning prostate tumors by iodine-123-iodoazomycin arabinoside. J Nucl Med. 1993;34(3):405.
Brown JM, William WR. Exploiting tumour hypoxia in cancer treatment. Nat Rev Cancer. 2004;4(6):437.
Yue XL, Yanez CO, Yao S, Belfield KD. Selective cell death by photochemically induced pH imbalance in cancer cells. J Am Chem Soc. 2013;135(6):2112.
Ferrari M. Cancer nanotechnology: opportunities and challenges. Nat Rev Cancer. 2005;5(3):161–171.
Ruoslahti E, Bhatia SN, Sailor MJ. Targeting of drugs and nanoparticles to tumors. J Cell Biol. 2010;188(6):759.
Yanez CO, Andrade CD, Belfield KD. Characterization of novel sulfonium photoacid generators and their microwave-assisted synthesis. Chem Comm. 2009;(7):827.
Tannock IF, Rotin D. Acid pH in tumors and its potential for therapeutic exploitation. Perspect Cancer Res. 1989;49(16):4373.
Haggie PM, Verkman AS. Unimpaired lysosomal acidification in respiratory epithelial cells in cystic fibrosis. J Biol Chem. 2009;284(12):7681.